Bristol-Myers Squibb Co. (BMY) PT Lowered to $48 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $48.00 (from $55.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
